CY1109131T1 - Φαρμακοτεχνικη μορφη βραδειας αποδεσμευσης για pralnacasan - Google Patents
Φαρμακοτεχνικη μορφη βραδειας αποδεσμευσης για pralnacasanInfo
- Publication number
- CY1109131T1 CY1109131T1 CY20091100457T CY091100457T CY1109131T1 CY 1109131 T1 CY1109131 T1 CY 1109131T1 CY 20091100457 T CY20091100457 T CY 20091100457T CY 091100457 T CY091100457 T CY 091100457T CY 1109131 T1 CY1109131 T1 CY 1109131T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pralnacasan
- pharmaceutical form
- evening
- release
- type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Δισκίο βραδείας αποδέσμευσης αποτελούμενο από τουλάχιστον δύο στρώσεις, το οποίο χαρακτηρίζεται από το γεγονός ότι τουλάχιστον μία στρώση απελευθερώνει αμέσως το φάρμακο 1S, 9S (RS, 3S) Ν-(2-αιθοξυ -5-οξο -τετραφουρανο -3-υλο) -6,10-διοξο -9-(ισοκινολινο -1-οϋλ -αμινο) -1,2,3,4,7,8,9,10 -οκταϋδρο -6Η-πυριδαζινο [1,2-a] [1,2] διαζεπινο -1-καρβοξαμίδιο και /ή τα άλατα του ή τα παράγωγα του και /ή τα ελεύθερα οξέα εξ' αυτών και ότι τουλάχιστον μία στρώση απελευθερώνει με καθυστέρηση το φάρμακο IS, 9S (RS, 3S) Ν-(2-αιθοξυ -5-οξο -τετραφουρανο -3-υλο) -6,10-διοξο -9-(ισοκινολινο -1-οϋλ -αμινο) -1,2,3,4,7,8,9,10 -οκταϋδρο -6Η-πυριδαζινο [1,2-a] [1,2] διαζεπινο -1-καρβοξαμίδιο και /ή και τα άλατα του ή τα παράγωγα του και /ή τα ελεύθερα οξέα εξ' αυτών για την θεραπεία αυτοάνοσων παθήσεων, διαβήτη τύπου I και τύπου II, ρευματοειδούς αρθρίτιδος, οστεοαρθρίτιδος και /ή ψωριάσεως.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005048293A DE102005048293A1 (de) | 2005-10-08 | 2005-10-08 | Retardformulierung für Pralnacasan |
| EP06805947A EP1937221B1 (de) | 2005-10-08 | 2006-09-29 | Retardformulierung für pralnacasan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1109131T1 true CY1109131T1 (el) | 2014-07-02 |
Family
ID=37764039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100457T CY1109131T1 (el) | 2005-10-08 | 2009-04-23 | Φαρμακοτεχνικη μορφη βραδειας αποδεσμευσης για pralnacasan |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8231904B2 (el) |
| EP (1) | EP1937221B1 (el) |
| JP (1) | JP2009511441A (el) |
| KR (1) | KR101362679B1 (el) |
| CN (1) | CN101277683B (el) |
| AT (1) | ATE422354T1 (el) |
| AU (1) | AU2006301573B2 (el) |
| BR (1) | BRPI0617184A2 (el) |
| CA (1) | CA2624838C (el) |
| CY (1) | CY1109131T1 (el) |
| DE (2) | DE102005048293A1 (el) |
| DK (1) | DK1937221T3 (el) |
| ES (1) | ES2322202T3 (el) |
| HK (1) | HK1124531A1 (el) |
| HR (1) | HRP20090254T1 (el) |
| IL (1) | IL190511A (el) |
| MA (1) | MA29803B1 (el) |
| ME (1) | ME01735B (el) |
| MY (1) | MY146552A (el) |
| NO (1) | NO339360B1 (el) |
| NZ (1) | NZ567268A (el) |
| PL (1) | PL1937221T3 (el) |
| PT (1) | PT1937221E (el) |
| RS (1) | RS50777B (el) |
| RU (1) | RU2419419C2 (el) |
| SI (1) | SI1937221T1 (el) |
| WO (1) | WO2007042160A1 (el) |
| ZA (1) | ZA200802031B (el) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX342120B (es) * | 2010-07-09 | 2016-09-14 | William Owen Wilkison | Combinación de sistema de liberación prolongada/inmediata para productos farmacéuticos de vida media corta como el remogliflozin. |
| WO2012020097A2 (en) * | 2010-08-13 | 2012-02-16 | Euro-Celtique S.A. | Use of binders for manufacturing storage stable formulations |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US5085865A (en) | 1989-04-12 | 1992-02-04 | Warner-Lambert Company | Sustained release pharmaceutical preparations containing an analgesic and a decongestant |
| IT1264696B1 (it) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
| FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| CN1524526A (zh) * | 2003-03-02 | 2004-09-01 | 颖 王 | 尼群地平双层缓释制剂 |
| US20050013863A1 (en) * | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
| CN1579401A (zh) * | 2003-08-11 | 2005-02-16 | 李亦武 | 一种止咳平喘药物新剂型及制备方法 |
| US7611728B2 (en) * | 2003-09-05 | 2009-11-03 | Supernus Pharmaceuticals, Inc. | Osmotic delivery of therapeutic compounds by solubility enhancement |
| WO2005048979A2 (en) * | 2003-10-06 | 2005-06-02 | Torrent Pharmaceuticals Limited | Pharmaceutical composition having casing with multiple micro tablets |
| WO2005051350A2 (en) * | 2003-10-28 | 2005-06-09 | Torrent Pharmaceuticals Limited | Water dispersible tablet |
-
2005
- 2005-10-08 DE DE102005048293A patent/DE102005048293A1/de not_active Ceased
-
2006
- 2006-09-29 PL PL06805947T patent/PL1937221T3/pl unknown
- 2006-09-29 JP JP2008533913A patent/JP2009511441A/ja active Pending
- 2006-09-29 SI SI200630266T patent/SI1937221T1/sl unknown
- 2006-09-29 CN CN2006800369452A patent/CN101277683B/zh not_active Expired - Fee Related
- 2006-09-29 PT PT06805947T patent/PT1937221E/pt unknown
- 2006-09-29 DE DE502006002851T patent/DE502006002851D1/de active Active
- 2006-09-29 AU AU2006301573A patent/AU2006301573B2/en not_active Ceased
- 2006-09-29 NZ NZ567268A patent/NZ567268A/en not_active IP Right Cessation
- 2006-09-29 ME MEP-2009-368A patent/ME01735B/me unknown
- 2006-09-29 DK DK06805947T patent/DK1937221T3/da active
- 2006-09-29 WO PCT/EP2006/009466 patent/WO2007042160A1/de active Application Filing
- 2006-09-29 CA CA2624838A patent/CA2624838C/en not_active Expired - Fee Related
- 2006-09-29 RU RU2008113381/15A patent/RU2419419C2/ru not_active IP Right Cessation
- 2006-09-29 AT AT06805947T patent/ATE422354T1/de active
- 2006-09-29 KR KR1020087008466A patent/KR101362679B1/ko not_active IP Right Cessation
- 2006-09-29 BR BRPI0617184-2A patent/BRPI0617184A2/pt not_active IP Right Cessation
- 2006-09-29 EP EP06805947A patent/EP1937221B1/de active Active
- 2006-09-29 RS RSP-2009/0174A patent/RS50777B/sr unknown
- 2006-09-29 ES ES06805947T patent/ES2322202T3/es active Active
- 2006-09-29 MY MYPI20080752A patent/MY146552A/en unknown
-
2008
- 2008-03-04 ZA ZA200802031A patent/ZA200802031B/xx unknown
- 2008-03-24 MA MA30779A patent/MA29803B1/fr unknown
- 2008-03-30 IL IL190511A patent/IL190511A/en not_active IP Right Cessation
- 2008-04-04 US US12/062,683 patent/US8231904B2/en not_active Expired - Fee Related
- 2008-04-21 NO NO20081896A patent/NO339360B1/no not_active IP Right Cessation
-
2009
- 2009-03-05 HK HK09102122.8A patent/HK1124531A1/xx not_active IP Right Cessation
- 2009-04-23 CY CY20091100457T patent/CY1109131T1/el unknown
- 2009-05-04 HR HR20090254T patent/HRP20090254T1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP099320A (es) | Compuestos de tetrahidropirrolopiracina sustituida y su aplicación en medicamentos | |
| BRPI0515473A (pt) | ligações bicìclicas imidazol-3-yl-amina substituìdas | |
| CL2008003116A1 (es) | Compuestos heterocíclicos bicíclicos; composición farmacéutica que comprende a dichos compuestos; y su uso en el tratamiento o prevención de enfermedades tales como diabetes, obesidad, trastorno metabólico, enfermedad cardiovascular entre otras. | |
| BRPI0514833A (pt) | fenilaminotiazóis substituìdos e seu uso | |
| CL2007003341A1 (es) | Compuestos derivados de imidazotriazinas; composicion farmaceutica, util para el tratamiento del cancer, arteroesclerosis y enfermedades cardiovasculares entre otras. | |
| UY30578A1 (es) | Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones | |
| DK2155866T3 (da) | Modificerede phosphataser | |
| BRPI0508403A (pt) | produtos de pelìcula tendo propriedades de desintegração controlada | |
| CL2004000255A1 (es) | Compuestos derivados del pirrol sustituidos con heterociclos, composicion farmaceutica, utiles para tratar osteoartritis, aneurisma, fiebre, enfermedades autoinmunes, psoriasis, asma, entre otras. | |
| MX2009001294A (es) | Granulo y tableta que se desintegra por vía oral que comprende oxicodona. | |
| CL2008001125A1 (es) | Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad. | |
| DE602007010664D1 (de) | P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen | |
| WO2009068214A3 (de) | Heteroaryl-substituierte piperidine | |
| ATE489371T1 (de) | Benzamidglucokinaseaktivatoren | |
| WO2006105538A3 (en) | Methods and compositions for treating il-21 related pathologies | |
| DE602004023125D1 (de) | Mehrlagige polymerfolien | |
| EA201070637A1 (ru) | Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н | |
| CR11397A (es) | Compuesto inhibidor de fosforilasa de glicogeno y composicion farmaceutica del mismo | |
| NO20090958L (no) | Behandling av revmatismesykdom med langsom frigivelse av glukokortikoid | |
| CY1109131T1 (el) | Φαρμακοτεχνικη μορφη βραδειας αποδεσμευσης για pralnacasan | |
| CL2009001436A1 (es) | Compuestos cristalinos de (1r,2s,3r)-1-(2-isoxazol-3-il)-1himidazol-4-il)butano-1,2,3,4-tetraol; utiles en el tratamiento y/o prevencion de asma, esclerosis multiple, artritis reumatoide, entre otras enfermedades. | |
| ITFI20060255A1 (it) | Composizione agrochimica, e metodo di trattamento di vegetali conmprendente la somministrazione di tale composizione | |
| ATE437857T1 (de) | Neuartige pyridinylaminalkylen- und pyridinyloxalkylen-cyclopropanamine, herstellungsverfahren dafür und pharmazeutische zusammensetzungen damit | |
| EA200900923A1 (ru) | Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний | |
| CL2007002981A1 (es) | Composicion farmaceutica que contiene 75 mg del isomero dextrogiro de clopidogrel y 300 mg de triflusal, util en el tratamiento de enfermedades tromboembolicas. |